Everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction: a randomized controlled trial : Coronary Artery Disease

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Original research

Everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction: a randomized controlled trial

Eriksen, Erlenda,b; Neghabat, Omeedc; Saeed, Sahraia; Herstad, Jona; Nordrehaug, Jan Erikb; Tuseth, Vegarda,b; Holm, Niels Ramsingc; Holck, Emil Nielsenc; Sejr-Hansen, Martinc; Maule, Camilla Foxc; Barkholt, Trine Ørhøjc; Andreasen, Lene Nyhusc; Christiansen, Evald Højc; Bleie, Øyvinda

Author Information
Coronary Artery Disease: November 23, 2022 - Volume - Issue - 10.1097/MCA.0000000000001202
doi: 10.1097/MCA.0000000000001202
  • Buy
  • SDC
  • PAP

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.